Jinu Abraham, PhD earned his doctoral degree in Molecular and Cellular Biology and as a postdoctoral researcher in the Keller laboratory has been investigating how rhabdomyosarcoma can, over time, begin to develop resistance to treatment by a class of drugs called tyrosine kinase inhibitors. He is the driving force behind the analysis and selection of novel therapeutic agents to be tested by the PPTI.
Elaine Huang, MSc received her M. Sc. in Immunology and begain working in an industry-sponsored GLP/GMP clinical cell and vaccine production facility. More recently she has been employed in a facility dedicated to generating genetically modified mice for the research community of OHSU. The PPTI will utilize her experience with animals and familiarity with industry standards to streamline the testing and analysis of drugs.
